[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity
Learn top tips for employing a pragmatic structured approach to digital transformation from a panel of experts at Merck
Find out how to construct a digital-enabled business model to enhance your digital transformation journey during this panel discussion with Merck
Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.
With these developments in mind, Pharma IQ’s upcoming panel discussion will feature industry-leading experts from Merck who will identify crucial steps required to navigate and harness the full potential of digital technologies in pharma. Using real-world examples, our expert panel will explain why having a structured methodology to digital transformation accelerates business growth, as well as revealing how to prevent silo mentalities from emerging.
Join this webinar to learn:
- The pragmatic short-term opportunities created through digital transformation.
- How to adapt the short-term opportunities for long-term digital business success.
- Top tips for getting started on your digital transformation journey.
- How to overcome challenges in R&D productivity and ensure a smooth transition into the digital age.
- The importance of having a digital data strategy to improve R&D opportunities.
Sign up now to secure your free place.
This webinar will take place at:
- 9am EST
- 6am PST
- 2pm GMT
- 3pm CET
Presenters:
Haydn Boehm
Head of Commercial Marketing - Connected Lab
Merck Group
Dr. Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector. Boehm has a PhD in Organic Chemistry from the University of Nottingham, UK.
Alessandra Pepe
AD Processes and Infrastructure Manager
Merck Group
Dr. Pepe has a PhD in cancer biology and DNA repair and extensive experience in development and validation of cell-based assays. In her current role, Dr. Pepe scouts, manages and coordinates efficiency and innovation projects to improve process efficiency and ensure operational and organizational excellence. As a certified Lean Six Sigma Green Belt, Dr. Pepe fosters sustainable continuous improvement initiatives and drives the implementation of lean processes through innovative and digital solutions.
Annette Hellbach
Director, Head of Science Enablement Tools
Merck Life Science
Dr. Annette Hellbach heads product management for Merck’s data management and analysis tools for the digital lab. She has many years of experience in the lab informatics industry and has worked with customers on questions of which data and IT strategy work best in transitioning labs to the digital age. Hellbach has studied molecular medicine and obtained her PhD in molecular biology and genetics from the Ludwig-Maximilians-University Munich/Max Planck Institute of Biochemistry.
